137 related articles for article (PubMed ID: 37877514)
1. A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Fertitta L; Bergqvist C; Sarin KY; Plotkin SR; Moertel C; Petersen AK; Cannon A; Berman Y; Pichard DC; Röhl C; Lessing A; Brizion B; Peiffer B; Ravaud P; Tran VT; Armand ML; Moryousef S; Ferkal S; Jannic A; Ezzedine K; Wolkenstein P;
Br J Dermatol; 2024 Jan; 190(2):216-225. PubMed ID: 37877514
[TBL] [Abstract][Full Text] [Related]
2. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
[TBL] [Abstract][Full Text] [Related]
3. Core outcomes for pressure ulcer prevention trials: results of an international consensus study: Classification: Outcomes and qualitative research.
Lechner A; Coleman S; Balzer K; Kirkham JJ; Muir D; Nixon J; Kottner J
Br J Dermatol; 2022 Nov; 187(5):743-752. PubMed ID: 35789479
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
[TBL] [Abstract][Full Text] [Related]
6. The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness.
Katiri R; Hall DA; Hoare DJ; Fackrell K; Horobin A; Hogan N; Buggy N; Van de Heyning PH; Firszt JB; Bruce IA; Kitterick PT;
Trials; 2022 Sep; 23(1):764. PubMed ID: 36076299
[TBL] [Abstract][Full Text] [Related]
7. A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
Jacobson ME; Rick JW; Gerbens LAA; Baghoomian W; Gould LJ; Marzano AV; Chen DM; Oakes DL; Dissemond J; Yamamoto T; Shinkai K; Nolan B; Lobato D; Thomas KS; Ortega-Loayza AG;
Br J Dermatol; 2024 Feb; 190(3):392-401. PubMed ID: 37952167
[TBL] [Abstract][Full Text] [Related]
8. Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials.
Cannon A; Pichard DC; Wolters PL; Adsit S; Erickson G; Lessing AJ; Li P; Narmore W; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR;
Neurology; 2021 Aug; 97(7 Suppl 1):S15-S24. PubMed ID: 34230202
[TBL] [Abstract][Full Text] [Related]
9. Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study.
Tellum T; Naftalin J; Chapron C; Dueholm M; Guo SW; Hirsch M; Larby ER; Munro MG; Saridogan E; van der Spuy ZM; Jurkovic D
Hum Reprod; 2022 Aug; 37(9):2012-2031. PubMed ID: 35906919
[TBL] [Abstract][Full Text] [Related]
10. Core outcome set for studies investigating management of selective fetal growth restriction in twins.
Townsend R; Duffy JMN; Sileo F; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ; Khalil A;
Ultrasound Obstet Gynecol; 2020 May; 55(5):652-660. PubMed ID: 31273879
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Multi-stakeholder contribution to the identification of a core outcome set and measurements in implant dentistry (ID-COSM initiative) using the Delphi methodology.
Sanz M; Carrillo de Albornoz A; Martín C; Needleman I; Tonetti MS
Clin Oral Implants Res; 2023 May; 34 Suppl 25():108-120. PubMed ID: 37232119
[TBL] [Abstract][Full Text] [Related]
13. Multi-stakeholder contribution to the identification of a core outcome set and measurements in implant dentistry (ID-COSM initiative) using the Delphi methodology.
Sanz M; Carrillo de Albornoz A; Martín C; Needleman I; Tonetti MS
J Clin Periodontol; 2023 May; 50 Suppl 25():107-121. PubMed ID: 37143293
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in neurofibromatosis 1: development and validation of a tool dedicated to cutaneous neurofibromas in adults.
Fertitta L; Bergqvist C; Armand ML; Moryousef S; Ferkal S; Jannic A; Ravaud P; Tran VT; Ezzedine K; Wolkenstein P
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1359-1366. PubMed ID: 35412677
[TBL] [Abstract][Full Text] [Related]
15. Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement (ID-COSM) international consensus report.
Tonetti MS; Sanz M; Avila-Ortiz G; Berglundh T; Cairo F; Derks J; Figuero E; Graziani F; Guerra F; Heitz-Mayfield L; Jung RE; Lai H; Needleman I; Papapanou PN; Sailer I; Sanz-Sanchez I; Schwarz F; Shi J; Thoma D
Clin Oral Implants Res; 2023 May; 34 Suppl 25():4-21. PubMed ID: 37232121
[TBL] [Abstract][Full Text] [Related]
16. Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement.
Simpson RC; Kirtschig G; Selk A; von Seitzberg S; Vittrup G; Bissonnette I; Kottner J; Lanthier J; Stanton C; Foster D; Promm M; Augenti A; Lauretti S; Thomas KS;
Br J Dermatol; 2023 Apr; 188(5):628-635. PubMed ID: 36702803
[TBL] [Abstract][Full Text] [Related]
17. Core Outcome Set for Actinic Keratosis Clinical Trials.
Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
[TBL] [Abstract][Full Text] [Related]
18. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals.
van Tol RR; Kimman ML; Melenhorst J; Stassen LPS; Dirksen CD; Breukink SO;
Colorectal Dis; 2019 May; 21(5):570-580. PubMed ID: 30628177
[TBL] [Abstract][Full Text] [Related]
19. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
[TBL] [Abstract][Full Text] [Related]
20. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Gerbens LA; Boyce AE; Wall D; Barbarot S; de Booij RJ; Deleuran M; Middelkamp-Hup MA; Roberts A; Vestergaard C; Weidinger S; Apfelbacher CJ; Irvine AD; Schmitt J; Williamson PR; Spuls PI; Flohr C
Trials; 2017 Feb; 18(1):87. PubMed ID: 28241851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
